INHIBITOR FOR THE ONSET AND PROGRESS OF LIVER CANCER TO BE USED IN HEPATITIS C VIRUS-POSITIVE HUMAN LIVER CIRRHOSIS PATIENTS

摘要

The present invention relates to an agent for inhibiting the development and / or progression of hepatocellular carcinoma in a human hepatitis C virus-positive patient. The present invention relates to a hepatocarcinogenesis agent for hepatitis C virus-positive human liver cirrhosis patients comprising three amino acids of isoleucine, leucine and valine / / RTI